Define haematinics. Describe iron metabolism, iron preparations, vitamin B12 and folic acid with their uses.
Definition and Iron Metabolism
Haematinics are substances required for the formation of blood — chiefly iron, vitamin B12 and folic acid.
Dietary iron is largely ferric (Fe3+) and must be reduced to ferrous (Fe2+) to be absorbed — helped by gastric acid and by ascorbic acid → Absorbed in the duodenum and upper jejunum through the DMT1 transporter → Within the enterocyte it is either stored as ferritin (and lost when the cell is shed) or exported → Export to plasma is through ferroportin → hepcidin, made by the liver, blocks ferroportin — it is the master regulator, rising in inflammation and iron excess → In plasma iron is carried on transferrin to the marrow and stored as ferritin and haemosiderin → There is NO physiological mechanism for excreting iron — balance is controlled entirely at absorption
CLINICAL PEARL
The body can absorb iron but cannot excrete it, and both halves of that sentence matter. Losses occur only through bleeding and shed cells, so regulation must happen at the gut, through hepcidin and ferroportin. This explains why repeated transfusion causes iron overload — transfused iron bypasses the absorptive control entirely and has nowhere to go — and why thalassaemia patients need chelation.
Iron Preparations
| Route | Preparations | Elemental iron and notes |
|---|---|---|
| Oral — preferred | Ferrous sulphate | 20% elemental iron; cheapest and most widely used; 200 mg tablet contains 60 mg elemental iron |
| Oral | Ferrous fumarate | 33% — the highest content |
| Oral | Ferrous gluconate | 12%; better tolerated by some |
| Oral | Carbonyl iron, iron polymaltose | Claimed better tolerance; more expensive |
| Parenteral | Iron sucrose, ferric carboxymaltose, ferric derisomaltose | Safe modern preparations; ferric carboxymaltose allows a large dose in one infusion |
| Parenteral — older | Iron dextran | Risk of anaphylaxis; a test dose was required; largely superseded |
- The usual therapeutic dose is 100 to 200 mg of elemental iron daily; prescriptions must specify elemental content, since salts differ several-fold
- Alternate-day dosing may be better absorbed than daily dosing, since a dose raises hepcidin for about 24 hours and blunts absorption of the next one
Factors Affecting Absorption, and Adverse Effects
- Enhanced by — ascorbic acid (vitamin C), gastric acid, meat and fish (haem iron), an empty stomach, and iron deficiency itself
- Reduced by — phytates (cereals, pulses), tannins in tea and coffee, calcium and milk, antacids, proton pump inhibitors, tetracyclines and fluoroquinolones (mutual chelation), and food generally
- Oral adverse effects — nausea, epigastric pain, metallic taste, constipation or diarrhoea, and black stools (harmless, but it masks melaena and confuses faecal occult blood testing). Tolerated better if taken with food, though absorption falls
- Parenteral adverse effects — injection site pain and staining, fever, arthralgia, hypophosphataemia (ferric carboxymaltose), and rarely anaphylaxis
- Parenteral iron is not faster at raising haemoglobin than oral iron in a patient who absorbs and takes it — it replaces stores more completely, which is a different advantage
Vitamin B12 and Folic Acid
| Feature | Vitamin B12 (cobalamin) | Folic acid |
|---|---|---|
| Preparations | Cyanocobalamin, hydroxocobalamin (longer acting, preferred) | Folic acid; folinic acid (leucovorin) which bypasses dihydrofolate reductase |
| Absorption | Requires intrinsic factor from gastric parietal cells; absorbed in the terminal ileum | Absorbed in the jejunum; no carrier protein needed |
| Body stores | Large — 3 to 5 years | Small — 3 to 4 months |
| Deficiency causes | Pernicious anaemia, gastrectomy, ileal resection or Crohn disease, metformin, proton pump inhibitors, strict vegan diet, fish tapeworm, bacterial overgrowth | Poor diet, alcoholism, pregnancy, haemolysis, malabsorption; drugs — methotrexate, trimethoprim, phenytoin, sulphasalazine |
| Neurological effects | Yes — subacute combined degeneration of the cord, peripheral neuropathy, dementia; may occur without anaemia | NO neurological syndrome |
| Route | Usually intramuscular in pernicious anaemia (lifelong); high-dose oral works through passive diffusion | Oral |
CLINICAL PEARL
Giving folic acid alone to a patient with vitamin B12 deficiency corrects the blood picture and lets the spinal cord degenerate. The megaloblastic anaemia improves, so both patient and doctor are reassured, while subacute combined degeneration progresses unchecked and becomes irreversible. That is why B12 must always be measured, or replaced first, before folate is given for a macrocytic anaemia.
Response to Treatment and Uses
- Expected response to iron — a sense of wellbeing within days; reticulocytosis peaking at 5 to 10 days; haemoglobin rising about 1 g/dL every 2 weeks. Treatment continues for 3 to 6 months after the haemoglobin normalises to replenish stores
- Failure to respond — consider non-adherence (much the commonest), continuing blood loss, wrong diagnosis (thalassaemia trait, anaemia of chronic disease), malabsorption, or coexisting B12 or folate deficiency
- Folic acid 5 mg periconceptionally prevents neural tube defects, and is given to all women planning pregnancy and at higher dose with antiepileptics or a previous affected child
- Folic acid is given routinely with methotrexate to reduce toxicity, and in chronic haemolysis where demand is high
- Hydroxocobalamin is also the antidote in cyanide poisoning, binding cyanide to form cyanocobalamin
Classification of Anaemia BY Cause and its Treatment
| Type | Cause | Treatment |
|---|---|---|
| Microcytic hypochromic | Iron deficiency — blood loss, poor intake, malabsorption, hookworm | Oral or parenteral iron, plus treatment of the cause |
| Microcytic — other | Thalassaemia trait, anaemia of chronic disease, sideroblastic anaemia | Iron is useless and potentially harmful; treat the underlying condition |
| Macrocytic megaloblastic | Vitamin B12 or folate deficiency | Replace the deficient vitamin — B12 first or together |
| Macrocytic non-megaloblastic | Alcohol, liver disease, hypothyroidism, myelodysplasia, reticulocytosis | Treat the cause |
| Normocytic | Anaemia of chronic disease (hepcidin traps iron in stores), renal failure, marrow failure, acute blood loss | Treat the disease; erythropoietin in renal failure |
| Haemolytic | G6PD deficiency, thalassaemia, sickle cell, autoimmune | Folic acid for the increased demand; steroids in autoimmune haemolysis; hydroxyurea in sickle cell disease; avoid oxidant drugs in G6PD deficiency |
- Prescribing iron for every anaemia is a common and harmful error — in thalassaemia trait and anaemia of chronic disease the stores are normal or raised, and adding iron achieves nothing while risking overload
Applied Aspects
- Iron deficiency anaemia is extremely common in India, particularly in women and children, from a phytate-rich low-meat diet, hookworm, malaria and repeated pregnancy; the Anaemia Mukt Bharat programme supplies iron and folic acid to at-risk groups
- Iron deficiency is a sign, not a diagnosis — in an adult man or a postmenopausal woman it requires investigation of the gastrointestinal tract for occult malignancy
- Advise taking iron with vitamin C or citrus, and away from tea, milk and antacids; drinking tea with meals is a genuine and common contributor in India
- Acute iron poisoning is a paediatric emergency — tablets look like sweets. It causes corrosive gastrointestinal injury and haematemesis, then an apparent recovery, then shock, metabolic acidosis and hepatic necrosis. Treated with desferrioxamine, and prevented by child-resistant containers
- Chronic iron overload from repeated transfusion in thalassaemia is treated with deferoxamine (parenteral), or oral deferasirox and deferiprone — the oral agents transformed adherence and survival in thalassaemia, which is common in parts of India
- Screen for B12 deficiency in long-term metformin users and in vegans, both of which are common in India; a macrocytosis or a neuropathy should prompt measurement rather than assumption
- Check the reticulocyte count at 5 to 10 days to confirm a response before assuming treatment failure; it rises well before the haemoglobin does
- Continue iron for 3 to 6 months after the haemoglobin normalises, or the stores remain empty and the anaemia returns within months
- Erythropoietin is the treatment for renal anaemia, not iron alone — though iron must be replete first or the erythropoietin cannot work
- Give folic acid in chronic haemolysis — thalassaemia, sickle cell disease and hereditary spherocytosis all consume folate rapidly through increased erythropoiesis
- Combined deficiency is common in malnutrition and malabsorption, and treating only one leaves the anaemia partly uncorrected and the diagnosis apparently wrong
- Blood transfusion is not a treatment for nutritional anaemia except in life-threatening decompensation; it carries real risks and does nothing about the cause
All questions in Blood, Haematinics & Anticancer Drugs
- Q1Define haematinics. Describe iron metabolism, iron preparations, vitamin B12 and folic acid with their uses. ★
- Q2Classify the haemostatic drugs. Describe vitamin K, tranexamic acid and the treatment of haemophilia. ★
- Q3Describe the general principles of cancer chemotherapy including the cell cycle, log kill hypothesis, combination therapy, resistance and toxicity. ★
- Q4Classify the cytotoxic anticancer drugs. Describe the alkylating agents, antimetabolites and natural products with their distinctive toxicities. ★
- Q5Describe the hormonal agents, targeted therapy and immunotherapy used in cancer. ★
- SN1Describe oral and parenteral iron therapy with the monitoring of response and the management of iron overload. ★
- SN2Describe vitamin B12 and folic acid with their deficiency states and treatment. ★
- SN3Describe the haematopoietic growth factors with their uses and adverse effects. ★
- SN4Describe methotrexate with its mechanism, uses, adverse effects and interactions. ★
- SN5Describe cisplatin and the platinum compounds with their uses and toxicity. ★
- SN6Describe the adverse effects of cancer chemotherapy and their prevention and management. ★
- SN7Classify the immunosuppressant drugs. Describe the calcineurin inhibitors and the complications of immunosuppression.